Attack Mounts on Drug Prices

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2002
Volume 26
Issue 9

Congress debates legislation for a Medicare drug benefit while the industry expresses concerns about import control, drug counterfeiting, and patent rights.

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Jens Schmidt, associate director MSAT at Lonza
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology